Doxorubicin (DOX) is a potent chemotherapeutic agent that has been used to treat cancer since the 1970’s. Although DOX has shown antitumor activity in a variety of cancer cells including sarcomas, it produces cardiac damage that is both cumulative and irreversible, which limits the lifetime dose that can be used. The serious and often fatal side effects of DOX call for the discovery and production of new drugs with greater effectiveness in the treatment of tumors. Sarcoma cancer is rare, but also one of the most deadly and difficult cancers to treat. Since DOX is one of the primary drugs used to treat sarcomas, it is critical to find an analog that will more effectively inhibit sarcoma tumor growth and can be used at a reduced dose. In this...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Cancer is the second leading cause of death in the United States, accounting for over 500,000 deaths...
Doxorubicin (DOX) is one of the primary drugs used to treat soft tissue sarcoma (STS). However, it s...
Doxorubicin (DOX) is one of the primary drugs used to treat soft tissue sarcoma (STS). However, it s...
In the US 1 in 8 women will develop breast cancer. Breast cancer is the second leading cause of canc...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
The scarcity of novel and effective therapeutics for the treatment of cancer is a pressing and alarm...
Doxorubicin (DOX) is a topoisomerase inhibitor used as a primary chemotherapeutic agent on soft tiss...
Doxorubicin (DOX) is a topoisomerase inhibitor used as a primary chemotherapeutic agent on soft tiss...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has seen widespread use to treat numerou...
Purpose: Multidrug resistance (MDR) of tumors to chemotherapeutics often leads to failure of cancer ...
Co-delivery of siRNAs and chemotherapeutic drugs to kill tumors have achieved superior tumor growth ...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Cancer is the second leading cause of death in the United States, accounting for over 500,000 deaths...
Doxorubicin (DOX) is one of the primary drugs used to treat soft tissue sarcoma (STS). However, it s...
Doxorubicin (DOX) is one of the primary drugs used to treat soft tissue sarcoma (STS). However, it s...
In the US 1 in 8 women will develop breast cancer. Breast cancer is the second leading cause of canc...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
Cancer is still a leading cause of death in the US, with approximately 1.7 million new cases of dise...
The scarcity of novel and effective therapeutics for the treatment of cancer is a pressing and alarm...
Doxorubicin (DOX) is a topoisomerase inhibitor used as a primary chemotherapeutic agent on soft tiss...
Doxorubicin (DOX) is a topoisomerase inhibitor used as a primary chemotherapeutic agent on soft tiss...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has seen widespread use to treat numerou...
Purpose: Multidrug resistance (MDR) of tumors to chemotherapeutics often leads to failure of cancer ...
Co-delivery of siRNAs and chemotherapeutic drugs to kill tumors have achieved superior tumor growth ...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Doxorubicin (DOX) is an anthracycline chemotherapeutic that has been used in the treatment of cancer...
Cancer is the second leading cause of death in the United States, accounting for over 500,000 deaths...